Vivitra 440 mg Infusion 1 is used to treat her2-positive breast cancer. It is a single-ingredient HER2 inhibitor medicine containing trastuzumab.
This medicine is used as an initial treatment or after chemotherapy for metastatic breast cancer. It is also used for gastric and gastroesophageal junction cancer. It also slows the growth of tumours that overexpress the HER2 protein.
Before starting, tell your doctor about your medical conditions and allergies. Tell the doctor about all other medicines, supplements or herbal products you take. Tell your doctor if you are pregnant, planning a pregnancy or breastfeeding. Attend any monitoring appointments advised by your doctor. Report persistent or serious side effects to your doctor. Do not stop taking or using the medicine unless your doctor advises you to do so.





































